DNA assembler is an efficient synthetic biology method for constructing and manipulating biochemical pathways. The rapidly increasing number of sequenced genomes provides a rich source for discovery of gene clusters involved in synthesizing new natural products. However, both discovery and economical production are hampered by our limited knowledge in manipulating most organisms and the corresponding pathways. By taking advantage of yeast in vivo homologous recombination, DNA assembler synthesizes an entire expression vector containing the target biosynthetic pathway and the genetic elements needed for DNA maintenance and replication. Here we use the spectinabilin clusters originated from two hosts as examples to illustrate the guidelines of using DNA assembler for cluster characterization and silent cluster activation. Such strategies offer unprecedented versatility in cluster manipulation, bypass the traditional laborious strategies to elicit pathway expression, and provide a new platform for de novo cluster assembly and genome mining for discovering new natural products. Curr. Protoc. Chem. Biol. 6:65-100 C 2014 by John Wiley & Sons, Inc.
INTRODUCTION
This article describes how to take full advantage of DNA assembler to study natural product biosynthesis. The majority of existing antibacterial and anticancer drugs are natural products or their derivatives (Li and Vederas, 2009; Newman and Cragg, 2012) . Over the last two decades, the complete genome sequences of more than 3000 organisms have been determined, and sequencing of more than 30,000 organisms is in progress. Genome mining has revealed that the natural products that have been characterized are merely "the tip of the iceberg," while plenty of metabolites await discovery (Omura et al., 2001; Bode and Muller, 2006; Ohnishi et al., 2008; Abed et al., 2009; Brakhage and Schroeckh, 2011) . However, the characterization and discovery of natural products are often hampered by our limited ability to manipulate the corresponding biosynthetic pathways. Most native producers cannot be cultivated in the laboratory, and tools for genetic manipulation are lacking (Davies, 1999) . Utilizing well-characterized organisms as heterologous hosts alleviates these problems to a certain extent, but this approach still suffers from problems with promoter recognition and gene expression, as well as the difficulty in performing sophisticated genetic modifications. The biosynthesis of natural products is highly regulated, and gene clusters often remain silent until suitable conditions are met (Bibb, 2005; Brakhage et al., 2008; Bibb and Hesketh, 2009; van Wezel et al., 2009) . Our current understanding of regulation hierarchy is not complete enough to predict the functions of all the regulatory elements. Thus, what are highly desirable in natural product studies are efficient approaches to rapidly manipulate large gene clusters and generic strategies that simplify regulation complexity, with no need to tailor efforts according to specific clusters. Here we use the spectinabilin gene clusters from Streptomyces spectabilis and Streptomyces orinoci as two examples to illustrate (1) how to apply DNA assembler to perform scar-less gene disruption and site-directed mutagenesis for rapid gene cluster characterization, and (2) how to reconstruct an artificial natural product gene cluster in order to decouple its expression from native sophisticated regulation cascades.
Spectinabilin is a nitrophenyl-containing polyketide that exhibits antimalarial and antiviral activities (Kakinuma et al., 1976; Isaka et al., 2002) . The two clusters from S. spectabilis and S. orinoci each consist of four polyketide synthases (PKSs), and the catalytic proteins from these PKSs share very high sequence homologies with each other (Fig. 1) . Examining the two clusters revealed two major differences. First, the S. spectabilis cluster (called as spn cluster or spn pathway hereafter) contains three extra genes, spnK, spnL, and spnM, which are missing from the S. orinoci cluster (referred to as the "nor cluster" or "nor pathway" hereafter) (Choi et al., 2010) . Second, these two clusters undergo different regulatory processes, as the spn cluster contains spnD, which encodes an activator, whereas the nor cluster contains norD, which encodes a repressor. When directly cloned into Streptomyces lividans, only the spn cluster could produce spectinabilin (Traitcheva, 2006; Choi et al., 2010) . To study the spectinabilin biosynthetic mechanism and identify the reason for the nor cluster being silent in S. lividans, in the following protocols, we first use DNA assembler to investigate the essentialness of spnK, spnL, and spnM in spectinabilin biosynthesis, then re-factor the nor pathway by replacing the native promoters with heterologous promoters, thus activating the silent cluster.
STRATEGIC PLANNING
The strategies are designed based on heterologous host expression, and two circumstances exist (Fig. 2) . In the first case, when the promoters from a native producer are recognized in a heterologous host, the direct cloning strategy will be used and an expression plasmid consisting of a pathway module and three helper modules will be assembled. The target gene cluster will be split into several pathway fragments, composing the pathway module. Each pathway fragment has a length of up to 6 kb. Pathway fragments are amplified by polymerase chain reaction (PCR) from the isolated genomic DNA of the native X X X X X X X X X
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Figure 2
The two strategies used to study natural product biosynthesis. Strategies should be selected based on the knowledge of whether the native promoters could be recognized in the heterologous host. Both strategies will rely on the DNA assembler technique to assemble pathways.
producer if it is cultivable, or they are chemically synthesized de novo. Three helper modules carrying the genetic elements needed for DNA maintenance and replication in S. cerevisiae (assembly host), E. coli (DNA enrichment host), and the target heterologous expression host are amplified from the corresponding vectors. Here, the minimal genetic elements include a selection marker used in each host and a functional element denoting whether the plasmid will be maintained in cytosol or integrated into a chromosome. Since PCR primers are designed to generate overlap regions between adjacent fragments, cotransformation of these fragments into S. cerevisiae will allow them to be assembled into a single DNA molecule through homologous recombination. The isolated plasmids are subsequently transformed to E. coli for plasmid enrichment and verification, and the correct construct is transformed into the desired host for heterologous expression of the target pathway.
However, in some cases, direct transferring of a cluster from a native producer to a heterologous host results in unrecognized promoters and thus unsuccessful expression. To overcome this problem, the gene cluster needs to be reconstructed. As shown in Figure 2 , the entire pathway module in the first case should be split into a few promoter modules and gene modules, whereas the helper modules can be maintained. The promoter modules are set up based on the choice of the expression host. Promoters can be chosen from the well-studied ones reported in the literature (unfortunately, these have not been reported in the literature for most organisms) or cloned from the potential promoter regions of endogenous housekeeping genes in the target expression host. Other organisms closely related to the target expression host can also be considered as effective sources for identifying promoters that can be recognized. After the promoter modules and the helper modules are set up, individual genes can be amplified or synthesized and plugged into each gene module. Overlaps are designed between adjacent fragments so that the reconstructed pathway can be assembled using the same procedures as in the direct cloning strategy. The expression of the pathway genes can be confirmed via real-time PCR, SDS-PAGE, and western blot (if a gene is tagged). The product can be identified using analytical methods such as LC-MS or biological activity assay. In some cases, inducible expression is desired because the final product or some of the biosynthetic intermediates are toxic to the expression host. An inducible promoter can be inserted upstream of the gene encoding the enzyme catalyzing the first step in the biosynthesis. From another point of view, in nature, secondary metabolites are mostly synthesized in stationary growth phase, when native producers do not need a lot of resources to support their primary metabolism. Therefore, the competition between primary metabolite biosynthesis and the target secondary metabolite biosynthesis for the precursors is at least partially relieved by the inclusion of an inducible promoter. Using such a modular design, the sophisticated regulation embedded in individual clusters is removed and replaced by a set of regulation that is predictable, easy to manipulate, and not specifically linked to any gene cluster. In other words, the native promoters are replaced by characterized promoters. As a side note, individual genes can be chemically synthesized de novo with optimized codons, resulting in a translationally improved pathway. All of these genetic manipulations are extremely difficult to accomplish by conventional methods.
In both methods mentioned above, in order to ensure high assembly efficiency, it is critical to design appropriate lengths of overlaps between adjacent fragments. For larger gene clusters (more than 20 kb), increasing the length of overlap is necessary for obtaining a decent efficiency. In the direct cloning strategy, as shown in Figure 3A , overlaps of approximately 400 bp between internal adjacent pathway fragments can be generated easily. For example, the forward primer for amplifying the second pathway fragment can be located ß400 bp upstream of the annealing position of the reverse primer for amplifying the first pathway fragment. In the cluster-reconstructing strategy, promoter modules and gene modules are separately prepared, and their in-between overlaps are generated by adding tails to primers; thus, they cannot be very long, and usually have lengths of 80 bp (Fig. 3B) . The overlaps between helper modules and adjacent fragments are 40 bp or 80 bp: we encountered difficulties in amplifying the S. cerevisiae helper fragment, and in the end, the correct product was only obtained by using the pair of primers without any tails. As a result, the S. cerevisiae helper fragment only overlaps with the last gene module and the adjacent helper fragment, with overlaps of 40 bp. Overlaps of 80 bp are generated between the other helper fragments and their neighbors. In both protocols, S. lividans, a laboratory strain that has been used extensively for studying gene clusters from Streptomycetes, is chosen as a target heterologous host owing to its high conjugative DNA transfer efficiency and the availability of several genetic manipulation tools (Woodyer et al., 2006; Felnagle et al., 2007; Baltz, 2010; Shao et al., 2011) .
CHARACTERIZATION OF THE spn GENE CLUSTER VIA DIRECT CLONING
As mentioned above, the spn gene cluster from S. spectabilis was previously successfully expressed in S. lividans (Choi et al., 2010) , indicating that the native promoters can be recognized by the heterologous host. When applying the direct cloning strategy, we start by assembling a wild-type pathway. In our initial trials, the ß45-kb spn pathway was split into 11 pathway fragments and each had a length of 4 to 6 kb. In principle, the number of pathway fragments to be assembled should be minimized, but low yield or even failure could occur more frequently when the PCR product is relatively long (>6 kb). However, a low assembly efficiency (<10%) was observed, and most of the constructs underwent severe gene deletion(s). The failure was due to the high sequence similarity among PKS domains. To address this issue, a modified two-step assembly strategy was devised (Fig. 4 ), through which we were able to assemble this biosynthetic pathway of 45 kb with an efficiency of 30%.
Materials
S. spectabilis genomic DNA isolated using Wizard Genomic DNA Purification Kit (Promega) FailSafe PCR 2×PreMix G (EPICENTRE Biotechnologies) Primers (Table 1) Phusion DNA polymerase and GC Reaction buffer (New England Biolabs) Dimethyl sulfoxide (DMSO) dNTP premix containing 10 mM each nucleotide Template plasmid pRS416 (New England Biolabs) Template plasmid pAE4 (New England Biolabs) QIAquick Gel Extraction Kit (Qiagen) 3 M sodium acetate 10 mg/ml glycogen 100% ethanol S. cerevisiae strain HZ848 or any auxotrophic S. cerevisiae strain (see annotation to step 5, below) YPAD medium (see recipe) 1 M sorbitol
The two-step strategy for assembling the spn pathway. 3. Load 100 μl of each of the PCR products obtained onto 0.7% agarose gels and perform electrophoresis at 120 V for 20 min (Voytas, 2000) . Gel-purify PCR products using the QIAquick Gel Extraction Kit. Check the concentrations of the purified products using a NanoDrop microspectrophotometer.
4. Prepare DNA fragment mixture for transformation.
a. Take 200 to 300 ng of each fragment, mix in a tube, and measure the final volume. Add 10% (v/v) of 3 M sodium acetate and 2% (v/v) of 10 mg/ml glycogen (e.g., if there is 100 μl of mixture, add 10 μl of sodium acetate and 2 μl of glycogen) and mix well. Add 2 volumes of 100% ethanol (e.g., if the final volume is about 110 μl, add 220 μl ethanol) and mix well. b. Store the DNA mixture at −80°C for at least 1 hr. c. Centrifuge 20 min at 16,100 × g, 4°C.
Usually the precipitated DNA can be seen at the bottom of the tube.
d. Remove the supernatant completely (do not touch the DNA). Add 500 μl of 70% ethanol to wash the DNA pellet, and centrifuge 3 min at 16,100 ×g, room temperature. e. Remove the ethanol completely and air dry the pellet for 1 to 2 min (do not over-dry). Resuspend the DNA pellet with 4 μl of distilled, deionized water. f. Now, the fragment mixture is ready for transformation. The fragment mixture can be maintained at −20°C for several months.
Transformation 5. Inoculate a single colony of S. cerevisiae strain HZ848 into 3 ml of YPAD medium and grow overnight at 30°C with shaking at 250 rpm.
S. cerevisiae HZ848 (MATα, Δura3, 15, 112, is used as the host for DNA assembly. However, any S. cerevisiae auxotrophic strain can be used as a host if the vector carrying the corresponding selection marker is provided.
6. Measure the OD 600 of the seed culture and inoculate the appropriate amount into 50 ml of fresh YPAD medium to obtain an OD 600 of 0.2 (e.g., if the overnight culture has an OD 600 of 10, then add 1 ml into 50 ml of fresh YPAD medium). The doubling time for a S. cerevisiae laboratory strain is approximately 2 hr. Continue growing the 50 ml of culture for ß4 hr to obtain an OD 600 of 0.8.
Prepare yeast cells for electroporation.
a. Spin down the yeast cells 10 min at 3220 × g, 4°C, and remove the spent medium. b. Use 50 ml of ice cold distilled deionized water to wash the cells once, and centrifuge again as in the previous step. c. Discard supernatant water, add 1 ml of ice-cold distilled deionized water to resuspend the cells, and transfer them to a sterile microcentrifuge tube. Microcentrifuge 30 sec at 4700 × g, 4°C. d. Remove water and use 1 ml of ice-cold 1 M sorbitol to wash the cells once (now the cells look slightly yellow). Microcentrifuge again as in step 7c, and remove the sorbitol. Resuspend the cells in 250 to 300 μl of chilled 1 M sorbitol and distribute them into 50-μl aliquots.
Now, each 50-μl aliquot of cells is ready for electroporation. Unlike E. coli, yeast competent cells need to be freshly prepared each time.
8. Electroporate and grow transformed cells.
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Volume 6 Current Protocols in Chemical Biology a. Mix 4 μl of DNA (from step 4f) with 50 μl of yeast cells and put the mixture into a chilled electroporation cuvette. b. Electroporate the cells at 1.5 kV, and quickly add 1 ml of pre-warmed (30°C) YPAD medium to resuspend cells. Transfer cells to sterile culture tubes.
For an efficient electroporation, a time constant of 5.0 to 5.2 msec should be obtained.
c. Grow at 30°C with shaking at 250 rpm for 1 hr. d. Microcentrifuge in a sterile tube 30 sec at 16,100 × g, and remove the YPAD medium. Use 1 ml of room temperature sorbitol solution to wash the cells two to three times using the same centrifugation conditions, and finally resuspend the cells in 1 ml of 1 M sorbitol. e. Spread 100 μl of resuspended cells onto SC-Ura plates. Incubate the plates at 30°C for 2 to 3 days until colonies appear.
Normally, 200 to 300 colonies will be obtained.
Verification of the correctly assembled constructs
Usually, ten colonies are randomly picked from the SC-Ura plate and each colony is inoculated into 1.5 ml of SC-Ura liquid medium.
9. Grow at 30°C for 1.5 days. Purify yeast plasmid DNA from each 1.5 ml of culture using the Zymoprep II kit. 11. Inoculate a single colony from each plate into 5 ml of LB supplemented with 50 μg/ml apramycin (added from 50 mg/ml stock), and grow at 37°C for 12 to 16 hr. Purify E. coli plasmids from each 5 ml of culture using the QIAprep Miniprep kit. Check the plasmid concentrations using a NanoDrop microspectrophotometer.
12. Verify the correctly assembled pathway through restriction digestion. Set up the following digestions to verify the three intermediate constructs. a. pZS-SpnDEFJAGKH: ApaLI digestion at 37°C for 3 hr; 1.5 μl of 10× NEBuffer, 0.15 μl of 100× BSA, 300 ng of plasmid, and 5 U of ApaLI. Add distilled, deionized water to a final volume of 15 μl. The second-step assembly The second-step assembly involves constructing the three intermediate fragments obtained in the first-step assembly into a backbone carrying Streptomyces helper module.
13. Construct a master helper plasmid by co-transforming the three PCR-amplified helper fragments, which share overlaps of 40 to 80 bp, into S. cerevisiae. E, Y, and S represent the corresponding E. coli, S. cerevisiae, and Streptomyces helper fragments (Fig. 4B ). PCR primers are listed in Table 1 and PCR reaction conditions for amplifying the helper fragments are illustrated in step 2. For amplifying the Streptomyces helper fragment, pAE4 is also used as a template and the condition is identical with amplifying the E. coli helper fragment.
The procedures performed in transformation and isolation of the master helper plasmid are identical with the ones used for constructing the above three intermediate plasmids (steps 5 to 11). To verify the correctly assembled master helper plasmid, set up ApaLI/XhoI digestion at 37°C for 3 hr: 5 μl of 10× NEB buffer, 1 μl of 100× BSA, 1 μg of plasmid, and 10 U of each enzyme. Add water to a final volume of 50 μl.
The expected sizes of the bands should be 1546 bp and 5116 bp. Gel purify the 5116-bp band using the QIAquick Gel Extraction Kit. Check the concentrations by NanoDrop.
14. Digest the confirmed intermediate plasmids with SspI and PacI to generate three intermediate fragments (Fig. 4B ).
Set up SspI/PacI digestion at 37°C for 3 hr: 5 μl of 10× NEBuffer, 1 μl of 100× BSA, 1 μg of plasmid, and 10 U of each enzyme. Add distilled deionized water to a final volume of 50 μl. Gel-purify the 17,775 bp, 11,739 bp, and 19,930 bp bands released from pZS-SpnDEFJAGKH, pZS-Spn(H)A (B), and pZS-SpnBCILM, respectively, using agarose gel electrophoresis (Voytas, 2000) and the QIAquick Gel Extraction Kit. Check the concentrations using a NanoDrop microspectrophotometer.
15. Mix 200 to 300 ng of intermediate fragments with a fragment obtained from restriction digestion of the master helper plasmid by ApaLI and XhoI. Concentrate the DNA mixture using the same procedures mentioned above.
16. Perform transformation and construct verification using the same procedures as for the intermediate constructs (step 5 to 12 under "Transformation" and "Verification of the correctly assembled constructs"). Set up the following digestions to verify the final construct (Fig. 4C ).
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Volume 6 Current Protocols in Chemical Biology a. ApaLI digestion at 37°C for 3 hr; 1.5 μl of 10× NEBuffer, 0.15 μl of 100× BSA, 1 μg of plasmid, and 10 U of ApaLI. Add distilled, deionized water to a final volume of 15 μl. Conjugation and heterologous expression of the spn pathway in S. lividans 17. Mix 50 to 100 ng of each verified plasmid with 50 μl of E. coli WM6026 cells and put the mixture into a chilled electroporation cuvette. Electroporate the cells at 2.5 kV, and quickly add 1 ml of SOC medium and 5 μl of 38 mg/ml DAP to resuspend cells. Grow at 37°C with shaking at 250 rpm for 1 hr. Spread 100 μl of each culture on a LB plate supplemented with 50 μg/ml apramycin and 190 μg/ml DAP. Incubate the plates at 37°C for 16 hr until colonies appear.
E. coli strain WM6026 is obtained from Professor William Metcalf and serves as the donor strain for conjugating plasmids to S. lividans (the details of strain construction can be obtained by request from the authors). It is an auxotrophic strain whose growth relies on exogenously supplemented DAP.
18. Inoculate a single colony from each plate into 2 ml of LB supplemented with 50 μg/ml apramycin and 10 μl of 38 mg/mL DAP, and grow at 37°C for approximately 2 hr until OD 600 reaches 0.6 to 0.8. Spin down 100 μl of cell culture in an microcentrifuge tube 30 sec at 3220 × g, room temperature, and wash the cell pellets each with 1 ml of fresh LB medium. Spin down the cells using the same centrifugation conditions, and wash one more time. Resuspend the cell pellets each with 1 ml of LB. Mix 2 μl of the resuspended cells with 25 μl of S. lividans spores by pipetting and spot 2 μl of aliquots onto R2-sucrose plates. Wait until all the spotted drops are absorbed into the plates. Incubate the plates at 30°C for 16 to 18 hr.
19. Flood the plates with 2 ml of a mixture of nalidixic acid and apramycin, each at a concentration of 1 mg/ml. Incubate the plates at 30 • C for additional 3 to 5 days, until exconjugants appear. Pick exconjugants and restreak onto ISP2-Apr plates. Allowed to grow for 2 days. Figure 5 LC-MS analysis of the S. lividans clones carrying the wild-type spn pathway and the mutant spn pathways. The asterisks indicate the spectinabilin peaks. MutK, the mutant with a stop codon introduced to SpnK; M, the mutant with SpnM deleted; M+L, the mutant with SpnM and SpnL deleted (Shao et al. 2011) . Reproduced by permission of The Royal Society of Chemistry.
22. Perform LC-MS on an Agilent 1100 series LC/MSD XCT plus ion trap mass spectrometer with an Agilent SB-C18 reversed-phase column using the following HPLC parameters for detection of spectinabilin:
Solvent A, 1% acetic acid in water; solvent B, acetonitrile; gradient, 10% B for 5 min to 100% B in 10 min, maintain at 100% B for 5 min, return to 10% B in 10 min, and finally maintain at 10% B for 7 min; flow rate 0.3 ml/min; detection by UV spectroscopy at 367 nm. Gene inactivation and scar-less gene deletion 23. To inactivate spnK, change the codon TGC encoding Cys199 to a stop codon TGA in the PCR primers (Table 1) . As shown in Figure 1 , spnK is split into two fragments that are amplified using the mutagenesis primers listed in Table 1 . Introducing a stop codon into the target gene located in the middle of the gene cluster instead of completely removing it has the advantage of maintaining the pathway structure without affecting the transcription of the neighboring genes. Remove the genes spnM and spnM+spnL individually from the biosynthetic pathway by redesigning the reverse primer for amplifying the last pathway fragment (Table 1) .
The assembly, verification, heterologous expression of the pathway variants, and detection of spectinabilin are performed using the same procedures as with the wild-type gene cluster.
As a result, all three mutants will still produce spectinabilin (Fig. 5) , indicating that spnK, spnL, and spnM are not required for spectinabilin biosynthesis, supporting our previous hypothesis that they are only involved in up-regulating the substrate concentration and product transportation (Choi et al., 2010 (Blodgett et al., 2007; Ito et al., 2009; Karray et al., 2010) , DNA assembler only requires adding site-specific mutation(s) into the PCR primers used to generate pathway fragments.
BASIC PROTOCOL 2

RECONSTRUCTING THE SILENT nor GENE CLUSTER FROM S. ORINOCI
As mentioned above, when the direct cloning strategy was applied to the nor gene cluster from S. orinoci, no spectinabilin was detected. Unlike the spn pathway, the nor pathway contains a repressor encoded by norD. Removing norD from the cluster did not lead to the production either, indicating that a more sophisticated regulation mechanism is embedded in spectinabilin biosynthesis in S. orinoci. The nor pathway therefore becomes a model pathway to test our cluster reconstructing strategy in activating silent gene clusters.
Our strategy is to select a single heterologous host, identify a set of promoters that are strong in the selected condition, assemble individual biosynthetic genes with these promoters into a new cluster, and express the reconstructed cluster in the selected condition (Fig. 2) . However, very few constitutive or inducible promoters have been characterized in Streptomycetes despite decades of research. In the following protocol, we will describe the procedures for identifying new promoters, confirming their activities, reconstructing the pathway, and consequently activating the silent cluster. Note that this method was recently published (Shao et al., 2013) . 2. Grow S. griseus under fixed culture conditions. Inoculate a single colony into 10 ml of MYG medium containing 20 to 30 3-to 4-mm glass beads and grow at 30°C with shaking at 250 rpm until the culture reaches saturation, which usually takes 2 days. Inoculate 2 ml of the saturated seed culture into 200 ml of fresh MYG 
Materials
Streptomyces griseus
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Volume 6 Current Protocols in Chemical Biology medium containing 200 to 300 glass beads of the same size and continue to grow under the same conditions. Collect 10 ml of culture every 12 hr. Centrifuge the samples 10 min at 3,220 × g, room temperature. Discard the supernatant. Store the pellets at −80°C. 
Total RNA extraction
The following protocol is designed based on the standard protocol provided in the RNeasy Mini Kit, with a few modifications.
3. Extract the total RNA using the RNeasy Mini Kit. Thaw samples on ice and resuspend cells using 1 ml of TE buffer containing 5 mg of lysozyme. Incubate the resuspended cells at 30°C with shaking at 250 rpm for 20 min.
All the tubes, tips, and water should be RNase-free.
4. Add 4 ml buffer RLT containing 400 μl of 2-mercaptoethanol. Mix completely by vortexing. Centrifuge 5 min at 3220 × g, room temperature. Transfer supernatant to a new tube. Take out 600 μl of the supernatant for the next steps and store the rest at −80°C.
5. Add 280 μl of 100% ethanol to the supernatant. Mix thoroughly by shaking. Do not centrifuge at this step. Transfer the sample to an RNeasy pink column, including any precipitate that may form. Microcentrifuge 1 min at 16,100 × g.
6. Wash the column using 400 μl of buffer RW1. Microcentrifuge 1 min at 16,100 × g. Wash the column using 250 μl of buffer RPE supplemented with ethanol. Microcentrifuge 1 min at 16,100 × g. Wash the column again using 250 μl of buffer RPE supplemented with ethanol. Microcentrifuge 1 min at 16,100 × g.
7.
Transfer the pink column to a new collection tube. Centrifuge 1 min at 16,100 × g and aspirate supernatant to remove residual ethanol.
8. Transfer the pink column to a new collection tube. Elute with 22 μl of RNase-free water. Wait for 1 min, then centrifuge 1 min at 16,100 × g.
The sample is ready for DNase treatment.
DNase treatment and cDNA synthesis 9. Add 2.5 μl of 10× TURBO DNase Buffer and 1 μl of TURBO DNase to the eluted RNA, and mix gently. Incubate at 37°C for 1 hr.
10. Add 3 μl of resuspended TURBO DNase inactivation reagent and pipet up and down to mix well. Incubate at room temperature for 5 min and mix occasionally by gently pipetting. Centrifuge 1.5 min at 10,000 × g, room temperature, and transfer the supernatant to a fresh tube. 1 μl of oligo dT primer or random hexamer (from first strand cDNA synthesis kit) 1 μl of RNase-free water 1 μl of 10 mM dNTPs (from first-strand cDNA synthesis kit).
Incubate at 65°C for 5 min and immediately put on ice for at least 1 min.
This step ensures denaturation of RNA secondary structures. Split the reaction mixture into halves.
12. Perform reverse transcription using the First-strand cDNA Synthesis Kit. To one half of the above mixture, add the following reagents:
4 μl of 5× first-strand buffer 1 μl of 0.1 M DTT 1 μl of RNase OUT recombinant RNase inhibitor 1 μl of Transcriptor reverse transcriptase (200 U/μl).
The second half of the mixture obtained in the last step will work as a negative control. Add everything in the above mixture except the reverse transcriptase and replace its volume with 1 μl of water. Mix gently and perform the cDNA synthesis using the following thermal cycling conditions: 25°C for 5 min, followed by 50°C for 30 min, and 70°C for 15 min, with a final holding temperature at 4°C.
Now the synthesized cDNA is ready for real-time PCR.
The negative reaction is used for monitoring the removal of genomic DNA in the DNase digestion step. The residual genomic DNA will give significant amplicons in real-time PCR.
Real-time PCR 13. Select and synthesize primers and select controls. (Nieselt et al., 2010; Gomez et al., 2011; Kim et al., 2011). 14. Prepare genomic DNA samples for constructing standard curves. Before setting up real-time PCR, prepare a serial dilution of S. griseus genomic DNA (isolated using the Wizard Genomic DNA Purification Kit). Measure the DNA concentration by Nanodrop and dilute the genomic DNA to concentrations of 64 ng/μl, 4 ng/μl, 0.25 ng/μl, 0.015625 ng/μl (16× serial dilution).
Genomic DNA is used for constructing standard curves because it provides a known ratio between the target genes and the internal control.
Set up the real-time PCR reactions as follows (final volume, 20 μl):
10 μl of SYBR Green PCR Master Mix 0.5 μl of forward primer (20 pmol/μl) 0. Confirming promoter activity 17. Clone the two abovementioned candidate promoters upstream of the Streptomycete reporter gene, xylE, encoding catechol 2, 3-dioxygenase. Previously, xylE has been cloned downstream of the promoter, ermE * p , in pAE4 vector, giving the construct pAE4-ermE*p-xylE. PCR-amplify the promoter from the S. griseus genomic DNA, and the first 262 bp sequence of xylE (before the NdeI site, named as xylE262) from pAE4-ermE*p-xylE. Restriction sites AflII and NdeI are incorporated into the primers (Table 3) . Set up PCR reactions using the standard protocol without DMSO. (B) Evaluation of the activities of the heterologous promoters using xylE as a reporter. actIp and ermE*p, the two commonly used promoters reported in the literature (Schmitt-John and Engels, 1992; Wilkinson et al., 2002; Wagner et al., 2009 ). The two letters in parentheses represent the names of individual actinomycetes. The xylE activity assay (Tobias Kieser et al., 2000) confirmed their much stronger activities than the control promoter, ermE* p . Reprinted with permission from Shao et al. (2013) . Copyright (2013) American Chemical Society.
Perform electrophoresis, gel-purify PCR products, and check the concentrations using the procedures described above. The promoter ermE * p is the mutated variant of the promoter of the erythromycin resistance gene from Saccharopolyspora erythraea, and is believed to be one of the strongest constitutive promoters in Streptomycetes (Schmitt-John and Engels, 1992; Wagner et al., 2009 Run the reactions using the standard PCR protocol (see Basic Protocol 1, step 1c). Perform agarose gel electrophoresis (Voytas, 2000) , gel-purify PCR products using the QIAquick Gel Extraction Kit, and check the concentrations using a Nanodrop microspectrophotometer.
19. Digest pAE4-ermE*p-xylE and the OE-PCR products (step 18) by AflII and NdeI at 37°C for 3 hr.
Digestion condition: 5 μl of 10× buffer, 1 μl of 100× BSA, 1 μg of OE-PCR product or 3 μg of pAE4-ermE*p-xylE, and 10 U of each enzyme per μg of DNA. Add distilled, deionized water to a final volume of 50 μl. Load the digestion products onto 0.7% agarose gels and perform electrophoresis at 120 V for 20 to 30 min (Voytas, 2000) . Gel-purify the digested OE-PCR product and the 5,545 kb band from pAE4-ermE * p-xylE digestion using the QIAquick Gel Extraction Kit and check the concentrations of the purified products using a NanoDrop microspectrophotometer. Shao et al. (2013) . Copyright (2013) American Chemical Society.
quickly add 1 ml of SOC medium to resuspend the cells. Grow at 37°C with shaking at 250 rpm for 1 hr. Centrifuge the cells, remove 800 μl of SOC medium, resuspend the pellet with the remaining 200 μl of SOC medium, and spread the entire volume on LB+Apr plates. Incubate the plates at 37°C for 16 to 18 hr until colonies appear.
22. Inoculate a single colony from each plate into 5 ml of LB+Apr liquid medium, and grow at 37°C for 12 to 16 hr. Purify E. coli plasmids from each 5 ml of culture using the QIAgen Miniprep kit. Check the plasmid concentrations by NanoDrop. Verify the correct clones through restriction digestion by AflII and NdeI.
23. Transform and conjugate the verified constructs into S. lividans using the same procedures described in Basic Protocol 1 for the spn pathway. Apply the same conditions used to prepare samples in promoter screening to express xylE. Collect samples at 24 hr and 48 hr and perform a XylE activity assay as described elsewhere (Tobias Kieser et al., 2000) . The same experiments are performed on pAE4-ermE * pxylE, which serves as a control.
A figure illustrating the expected result is shown in Figure 6B . (Krasny et al., 2000; Suarez et al., 2006; Ahn et al., 2007; Shao et al., 2009; Hong et al., 2010; Ahmad et al., 2012; Jia et al., 2012) . Cloning additional promoters 24. Clone the corresponding gapdh p and rpsL p from other actinobacteria. Their sequences may be downloaded from the NCBI Web site. Here, we choose 18 distinct actinobacteria ( 25. Obtain promoters from these hosts through primer splicing, in which 6 to 10 overlapping oligonucleotides designed based on the sequence of each promoter are joined through overlap extension PCR (Fig. 7) . Set up the first-step reaction mixture as follows:
10 μl of FailSafe PCR 2× PreMix G 0. 
90
Volume 6 Current Protocols in Chemical Biology 10 μl of first-step reaction mixture 1 μl of Phusion DNA polymerase 2.5 μl of the first primer and the last primer (20 pmol/μl) 2.5 μl of reverse primer (20 pmol/μl) 34 μl distilled, deionized H 2 O.
Run the reactions using the standard PCR protocol (see Basic Protocol 1, step 1c). Perform agarose gel electrophoresis, gel-purify PCR products using the QIAquick gel purification kit, and check the concentrations using a Nanodrop microspectrophotometer.
26. Splice the promoters individually with the fragment xylE262 via overlap extension PCR, clone the resulting product into pAE4, and perform XylE assay using the same procedures as with gapdh p (SG) and rpsL p (SG).
As a result, 13 out of the 36 promoter candidates should be shown to be very active in S. lividans, many of them having more than 10-fold higher activities than ermE* p (Fig. 6B ).
Reconstructing the nor cluster 27. Pick nine strong constitutive promoters from the collection to drive the expression of the nor pathway genes except for norD and norG. (Herai et al., 2004) (Fig. 8A ).
28. Use the previously mentioned 2-step assembly strategy to reconstruct the 42.6-kb nor pathway. Design primers to give overlaps of 80 bp between promoters and genes ( Fig. 3B and Table 5 ). Amplify the promoters from the corresponding pAEpromoter-xylE plasmids and amplify pathway genes from the genomic DNA of S. orinoci (purified using Wizard Genomic DNA Purification Kit). Similar to the first step in the assembly of the spn pathway, the first-step assembly will result in three intermediate plasmids (Fig. 8B ). Perform restriction digestion on the verified constructs by AvrII and SspI to release intermediate pathway fragments, which will subsequently be combined with the master helper fragment as a full-length nor pathway in the second-step assembly. The transformation and verification protocols are the same with those for the spn pathway.
Expressing the reconstructed nor cluster and detecting the product 29. Follow Basic Protocol 1, steps 17 to 20, to conjugate the assembled final construct to S. lividans. Pick the resulting exconjugants and restreak on ISP2+Apr plates and allow growing for 2 days. Inoculate a single colony into 10 ml of MYG medium supplemented with 50 μg/ml apramycin and grow at 30°C for 2 days as a seed culture, of which 2.5 ml will be subsequently inoculated to 250 ml of fresh MYG medium. Incubate the culture at 30°C with shaking at 250 rpm for 5 days. Add the inducer, ε-caprolactam, to the culture at a concentration of 1 g/liter after 12 hr, and collect samples at appropriate times afterward. Follow the same protocol for spectinabilin extraction and detection (see Basic Protocol 1).
As an expected result, the reconstructed pathway should be successfully activated, with a titer of approximately 0.1 mg/liter (Fig. 9) . into the solution before autoclaving. After the solution cools down to 70°to 80°C, add 1 ml of 50 mg/ml apramycin for LB+Apr plates and additionally add 5 ml of 38 mg/ml 2,6-diaminopimelic acid (DAP; Sigma, cat. no. D1377) for LB +Apr+DAP plates. Pour 20 to 25 ml into each 100-mm petri dish. Store up to 6 months at 4ºC.
MYG liquid medium
Add 10 g malt extract, 4 g yeast extract, and 4 g glucose to 1 liter of distille, deionized water. Adjust pH to 7.2 with NaOH. Autoclave at 121°C for 15 min. Store up to 6 months at room temperature.
R2-sucrose agar plates
Add 0.25 g of K 2 SO 4 , 10.12 g of MgCl 2 ·6H 2 O, 10 g of glucose, 0.1 g of Difco casamino acids, and 5.73 g of TES (Sigma, cat. no. T1375) into 990 ml of deionized water. Autoclave at 121°C for 15 min. After the solution cools down to 70°to 80°C, add 1 ml of 5 mg/ml KH 2 PO 4 , 8 ml of 36.8 mg/ml CaCl 2 ·2H 2 O, 1.5 ml of 0.2 g/ml L-proline, and 0.5 ml of 1 M NaOH (all these solutions need to be filter-sterilized in advance). Pour 20 to 25 ml into each 100-mm petri dish. Store up to 6 months at 4ºC.
121°C for 15 min. To make SC-Ura plates, add 12 g agar before autoclaving. Store up to 6 months at 4ºC.
SOC medium
Add 20 g Bacto-tryptone, 5 g yeast extract, 0.5 g NaCl, and 186.4 mg KCl to 980 ml of distilled, deionized water. Adjust pH to 7.0 with NaOH. Autoclave at 121°C for 15 min. After the solution cools down to 70°to 80°C, add 20 m of sterile 1 M glucose. Store up to 6 months at 4ºC.
TE buffer
10 mM Tris·Cl, pH 8.0 (adjust pH with HCl) 1 mM EDTA Store up to 1 year at room temperature
YPAD medium
Dissolve 6 g yeast extract, 12 g peptone, 12 g dextrose, and 60 mg adenine hemisulfate in 600 ml distilled, deionized water. Autoclave at 121°C for 15 min. Store up to 6 months at room temperature.
COMMENTARY Background Information
Microorganisms and plants produce numerous secondary metabolites or natural products, which are a prolific source of therapeutic agents (Herbert, 1989; Dewick, 2002; Li and Vederas, 2009 ). For example, it has been estimated that 77% of antibacterial drugs and 78% of anticancer drugs are either natural products or their derivatives (Newman and Cragg, 2012) . Existing strategies for characterizing natural product gene clusters can be broadly classified into two groups, including the native host gene inactivation method and the heterologous host gene expression method (Shao et al., 2011) . The native host-based method involves introducing mutation(s) and deleting gene(s) directly from the chromosome and comparing the metabolite profile of the mutant with that of the wild type. In comparison, the heterologous host-based method involves moving the gene cluster from the native producer to a secondary host and comparing the metabolite profile of the resulting strain with that of the background strain. However, both approaches suffer from a few limitations. For the native host-based method, firstly, most native producers are not cultivable in the laboratory and many microorganisms grow very slowly and produce minute amount of target compounds. It has been estimated that only 1% of bacteria and 5% of fungi have been cultivated in the laboratory (Bull et al., 1992; Davies, 1999; Leadbetter, 2003; Demain, 2006) . Secondly, genetic tools have not been developed for the majority of organisms, which makes manipulation of a target biosynthetic pathway inconvenient and inefficient, since each host has to be examined individually. On the other hand, the heterologous host-based method suffers from difficulties in the transfer and genetic manipulation of large biosynthetic pathways (>30 kb), problems with promoter recognition and gene expression, the limited availability of expression hosts, and low yield (Gross, 2007) . Therefore, it is highly desirable to establish novel efficient modification, transfer, and expression technologies.
Moreover, recent advances in DNA sequencing technologies and bioinformatics indicate that sequenced genomes and metagenomes may represent a tremendously rich source for discovery of novel pathways involved in natural product biosynthesis (Challis, 2008; Zerikly and Challis, 2009 ). However, only a tiny fraction of these biosynthetic pathways have been characterized. For example, genome mining of Streptomyces (Omura et al., 2001; Ohnishi et al., 2008) , myxobacteria (Bode and Muller, 2006) , cyanobacteria (Singh et al., 2005; Abed et al., 2009) , and fungi (Brakhage and Schroeckh, 2011) revealed the presence of many cryptic pathways whose products have not been identified, while these strains were previously known to produce only a few compounds before their genomes were sequenced. The biosynthesis of natural products is highly regulated, and the regulation is conducted through dozens of pleiotropic regulatory genes and pathwayspecific regulators (Bibb, 2005; Brakhage et al., 2008; Bibb and Hesketh, 2009; van Wezel et al., 2009) . They interact with each other to form an extremely complex network in response to a variety of physiological and environmental signals. These embedded complex regulations always hamper the discovery of novel natural products. Existing approaches to elicit pathway expression mainly include: (1) manipulating cell culture parameters, such as medium composition, to ensure expression of pathway-specific activator(s), presence of physiological and environmental co-inducer(s), or de-repression of the genes repressed by repressor(s) (Brakhage et al., 2008; van Wezel et al., 2009 ); (2) engineering the regulation by expressing the pathway-specific regulator under a well-characterized promoter (Wendt-Pienkowski et al., 2005; Bergmann et al., 2007) ; (3) testing a variety of heterologous hosts to express the target cluster (Baltz, 2010) ; (4) silencing major secondary metabolite biosynthetic pathways in order to simplify product identification and relieve competition for key precursors (Komatsu et al., 2010) ; (5) utilizing industrial strains that have been set up for high-level production of specific compounds (Rodriguez et al., 2003) . Obviously, all these strategies can only be applied on a case-by-case basis. Each gene cluster has its own unique regulatory mechanism that has to be examined individually in order to identify the suitable context for the cluster to be activated. Such methods suffer from the laborious procedure, lack general applicability, and repeatedly identify compounds that are already known.
The strategy we present here remedies several of the key drawbacks associated with the traditional native host-based method and the heterologous host-based method, offering a powerful way to study natural product biosynthetic clusters and shedding light on deciphering cryptic pathways identified from genome mining (Gross, 2007; Challis, 2008; Zerikly and Challis, 2009 ).
Critical Parameters
The direct cloning strategy is used mostly when the cluster has been demonstrated to be functional in the heterologous host, and the product has been identified, but the biosynthetic mechanism has not been fully clarified. This strategy bypasses the conventional time-consuming processes for performing gene disruption, and could easily be used to introduce fine modifications without any remaining markers. On the other hand, the cluster-reconstructing strategy is more generic and can be applied when the cluster in the background of native regulation is not guaranteed in the heterologous host. When the product from the reconstructed pathway has been successfully identified, the concepts of introducing gene disruption and fine modifications in the direct cloning strategy can easily be applied. The key steps in the cluster reconstructing strategy include: (1) determine an ideal expression host, which in general should be closely related to the native producer in order to provide both necessary precursors and a similar environment for protein translation and folding. The choice of the expression host should also be made based on the availability of genetic tools to manipulate the organism. For example, S. lividans was used as a host to express clusters from other Streptomyces species (Tobias Kieser et al., 2000; Woodyer et al., 2006; Felnagle et al., 2007; Eliot et al., 2008; Feng et al., 2009 ) and S. cerevisiae was used to express clusters from fungi (Ishiuchi et al., 2012; Wawrzyn et al., 2012) . (2) Identify a set of strong constitutive promoters. Except for E. coli and S. cerevisiae, most organisms do not have such a set of promoters reported in the literature for ready use. Thanks to the development of real-time PCR and RNA-seq, strong constitutive promoters can be identified rapidly from the upstream regions of the housekeeping genes in the selected expression host. The culturing conditions for promoter identification will subsequently be used to produce the target compound, such that the transcription of each pathway gene is forced to be turned on. As we demonstrate here, promoters from closely related organisms have a very high chance to be recognized by the transcription machinery in the selected host. Note that these promoters could undergo unknown regulations in the target host, and thus might not be completely constitutive. But, at least, transcription of the downstream genes should consistently be observed. (3) PCR-amplify pathway genes from the target cluster using primers that will generate an overlap between adjacent fragments, and refactor the cluster using DNA assembler in S. cerevisiae. Several other DNA assembly methods, such as Gibson cloning (Gibson et al., 2009) , RecET mediated direct cloning (Cobb and Zhao, 2012; Fu et al., 2012) , and reiterative recombination (Wingler and Cornish, 2011) , which are all based on homologous recombination, have been reported recently. DNA assembler is known for its easy protocol and high assembly accuracy for large constructs by taking advantage of yeast in vivo homology recombination. Pathways up to 50 kb can be assembled routinely within 1 to 2 weeks with an efficiency of 30% to 100% (Shao et al., 2011) . Such an in vivo homologous recombination-based assembly has also been used to assemble molecules as large as a genome (Gibson et al., 2008) . Combined with the rapid promoter identification mentioned above, the method we propose here enables pathway design and manipulation in any desired organism as easily as in E. coli and S. cerevisiae. Codons can be optimized at this step if needed. (4) Express the cluster in the selected host and identify the product. Metabolites extracted from the expression host carrying the refactored cluster are usually analyzed by liquid chromatography and compared with those extracted from the host lacking the exogenous pathway or carrying a non-functional pathway (e.g., a pathway with an essential gene deleted or mutated). Compounds appearing as new peaks are purified and subjected to mass spectrometry or NMR analysis for structure clarification.
Troubleshooting
PCR
In some cases, especially for amplifying certain fragments from Streptomyces, finetuning of the annealing temperature is often necessary for obtaining the correct amplicons or improving PCR yields. Due to the high GC content of the Streptomyces genome (>70%), including 5% DMSO in the reaction mixture will reduce the chance of forming secondary structures in general, resulting in better amplification efficiency. However, in some cases, we did encounter lower amplification efficiencies or even failures when DMSO was used. 58°C is used as a standard annealing temperature. Generally, when difficulties are encountered in amplifying a certain fragment, a set of PCR conditions with various annealing temperatures, and inclusion or exclusion of 5% of DMSO, need to be tested.
Real-time PCR
Primers for real-time PCR are designed according to the online software (http://www.idtdna.com/scitools/Applications/ RealTimePCR/) provided by Integrated DNA Technologies. For each reaction, a dissociation curve should be examined to ensure the reaction quality. Nonspecific amplification will result in more than one major peak, in which case new primers need to be tried.
Pathway assembly
The failure in using one-step assembly to construct the spn pathway was not due to the large size of the cluster, because clusters of similar sizes (ß50 kb) can be routinely obtained in our laboratory. Whether high sequence similarity between genes could potentially be problematic in assembly varies on a case-by-case. It did not seem to be a problem in the assembly of the aureothin gene cluster, which has three PKSs (Shao et al., 2011) . The one-step assembly works efficiently for most gene clusters lacking highly repeated sequences. When handling clusters containing highly repeated sequences, we recommend attempting the one-step assembly first, and if it fails, then the cluster should be split into a couple of smaller intermediate plasmids as described above.
Anticipated Results
For a construct of less than 20 kb, an assembly efficiency of 70% to 100% is expected, and for a construct of 20 to 50 kb, an assembly efficiency of at least 30% is expected.
Time Considerations
The corresponding time required by each major step is listed in Table 6 .
